• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌肝转移的发生时间。

The time of occurrence of liver metastasis in carcinoma of the pancreas.

作者信息

Amikura K, Kobari M, Matsuno S

机构信息

First Department of Surgery, Tohoku University School of Medicine, Sendai, Japan.

出版信息

Int J Pancreatol. 1995 Apr;17(2):139-46. doi: 10.1007/BF02788531.

DOI:10.1007/BF02788531
PMID:7622937
Abstract

By measuring the doubling time of liver metastasis, the authors investigated the possibility of occult liver metastasis at the time of pancreatectomy in patients with pancreatic carcinoma. We calculated tumor doubling times of liver metastases in six patients after pancreatectomy for periampullary carcinoma and compared with cell doubling times. We also calculated the diameters of the occult liver metastases at the time of pancreatectomy on the assumption that the growth rates of liver metastasis were constant. Tumor doubling times of liver metastases in six patients were 34, 32, 318, 108, 78, and 27 d, respectively. In two of these patients, tumor doubling times, compared with cell doubling times of 51 and 52 h for PK-36 and PK-59 established from the same patients with carcinoma of the pancreas, were about 15 times as long as those of cultured cell lines. The calculated sizes of the occult liver metastases at the time of pancreatectomy in these six patients were 2.4, 0.14, 19.0, 8.2, 3.5, and 4.2 mm. In five of these six patients, the calculated sizes were in the range between 10 microns and 1 cm. These results indicated occult liver metastases had already existed in patients with carcinoma of the pancreas at the time of pancreatectomy and were too small to be detected by imaging technique. We cannot improve survival rates in carcinoma of the pancreas by surgical management alone. For further improvement in survival rate of patients with carcinoma of the pancreas to occur, effective adjuvant therapies to prevent liver metastases must complement surgical management.

摘要

通过测量肝转移灶的倍增时间,作者研究了胰腺癌患者在胰十二指肠切除时存在隐匿性肝转移的可能性。我们计算了6例壶腹周围癌患者胰十二指肠切除术后肝转移灶的肿瘤倍增时间,并与细胞倍增时间进行比较。我们还假设肝转移灶的生长速率恒定,计算了胰十二指肠切除时隐匿性肝转移灶的直径。6例患者肝转移灶的肿瘤倍增时间分别为34、32、318、108、78和27天。其中2例患者的肿瘤倍增时间,与从同一胰腺癌患者建立的PK - 36和PK - 59细胞系的细胞倍增时间(分别为51和52小时)相比,约为培养细胞系的15倍。这6例患者胰十二指肠切除时隐匿性肝转移灶的计算大小分别为2.4、0.14、19.0、8.2、3.5和4.2毫米。在这6例患者中的5例中,计算大小在10微米至1厘米之间。这些结果表明,胰腺癌患者在胰十二指肠切除时已经存在隐匿性肝转移,且转移灶太小,无法通过影像学技术检测到。仅通过手术治疗无法提高胰腺癌患者的生存率。为了进一步提高胰腺癌患者的生存率,必须采用有效的辅助治疗来预防肝转移,以补充手术治疗。

相似文献

1
The time of occurrence of liver metastasis in carcinoma of the pancreas.胰腺癌肝转移的发生时间。
Int J Pancreatol. 1995 Apr;17(2):139-46. doi: 10.1007/BF02788531.
2
[The growth rates of liver metastases in pancreatic cancer--comparison on growth rates between clinical cases and established human pancreatic cancer cell lines].[胰腺癌肝转移的生长速率——临床病例与已建立的人胰腺癌细胞系生长速率的比较]
Nihon Geka Gakkai Zasshi. 1991 May;92(5):562-6.
3
Pleomorphic carcinoma of the pancreas: reappraisal of surgical resection.胰腺多形性癌:手术切除的重新评估
Am J Gastroenterol. 1998 Jul;93(7):1151-5. doi: 10.1111/j.1572-0241.1998.351_e.x.
4
Pancreatic liver metastases after curative resection combined with intraoperative radiation for pancreatic cancer.胰腺癌根治性切除联合术中放疗后发生肝转移。
Hepatogastroenterology. 2004 Sep-Oct;51(59):1500-3.
5
Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma.射频消融治疗局部控制的胰腺导管腺癌患者肝转移。
J Vasc Interv Radiol. 2012 May;23(5):635-41. doi: 10.1016/j.jvir.2012.01.080.
6
Solid pseudopapillary tumor of the pancreas with liver metastasis: Clinical features and management.胰腺实性假乳头状瘤伴肝转移:临床特征与治疗
Eur J Surg Oncol. 2014 Nov;40(11):1572-7. doi: 10.1016/j.ejso.2014.05.012. Epub 2014 Jun 12.
7
Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.伴有同步肝转移的胰腺导管腺癌的术前评估:不可切除性的诊断与评估
World J Gastroenterol. 2016 Dec 7;22(45):10024-10037. doi: 10.3748/wjg.v22.i45.10024.
8
[Surgical Resection of Metachronous Hepatic Metastasis from Pancreatic Acinar Cell Carcinoma after Total Pancreatectomy].[全胰切除术后胰腺腺泡细胞癌异时性肝转移的手术切除]
Gan To Kagaku Ryoho. 2015 Nov;42(12):2403-5.
9
Long-term Survival After Surgical Treatment of Renal Cell Carcinoma Metastasis Within the Pancreas.肾细胞癌胰腺转移灶手术治疗后的长期生存情况。
Anticancer Res. 2016 Aug;36(8):4273-8.
10
Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy.胰腺癌根治性切除术后残胰发生的第二原发性胰腺导管癌:术后5年累积发病率较高。
Pancreatology. 2016 Jul-Aug;16(4):615-20. doi: 10.1016/j.pan.2016.05.003. Epub 2016 May 14.

引用本文的文献

1
The Clonal Trajectory of Liver and Lung Metastases in Pancreatic Ductal Adenocarcinoma.胰腺导管腺癌肝转移和肺转移的克隆轨迹
Cancer Rep (Hoboken). 2025 May;8(5):e70228. doi: 10.1002/cnr2.70228.
2
The impact of AMIGO2 on prognosis and hepatic metastasis in gastric cancer patients.AMIGO2 对胃癌患者预后和肝转移的影响。
BMC Cancer. 2022 Mar 16;22(1):280. doi: 10.1186/s12885-022-09339-0.
3
G-protein subunit gamma-4 expression has potential for detection, prediction and therapeutic targeting in liver metastasis of gastric cancer.

本文引用的文献

1
Time of occurrence of pulmonary metastasis from carcinoma of colon and rectum.结肠直肠癌肺转移的发生时间。
Cancer. 1962 Mar-Apr;15:387-95. doi: 10.1002/1097-0142(196203/04)15:2<387::aid-cncr2820150222>3.0.co;2-5.
2
Observations on growth rates of human tumors.关于人类肿瘤生长速率的观察
Am J Roentgenol Radium Ther Nucl Med. 1956 Nov;76(5):988-1000.
3
Recurrence of exocrine pancreatic cancer--local or hepatic?胰腺外分泌癌的复发——局部复发还是肝转移?
G 蛋白亚基 γ-4 的表达可能有助于胃癌肝转移的检测、预测和治疗靶点的选择。
Br J Cancer. 2021 Jul;125(2):220-228. doi: 10.1038/s41416-021-01366-1. Epub 2021 Apr 14.
4
Morphofunctional analysis of human pancreatic cancer cell lines in 2- and 3-dimensional cultures.二维和三维培养条件下人胰腺癌细胞系的形态功能分析。
Sci Rep. 2021 Mar 24;11(1):6775. doi: 10.1038/s41598-021-86028-1.
5
The Evolutionary Origins of Recurrent Pancreatic Cancer.复发性胰腺癌的进化起源。
Cancer Discov. 2020 Jun;10(6):792-805. doi: 10.1158/2159-8290.CD-19-1508. Epub 2020 Mar 19.
6
Hepatocellular Carcinoma Demonstrates Heterogeneous Growth Patterns in a Multicenter Cohort of Patients With Cirrhosis.肝细胞癌在肝硬化多中心队列患者中表现出异质性生长模式。
Hepatology. 2020 Nov;72(5):1654-1665. doi: 10.1002/hep.31159. Epub 2020 Oct 25.
7
An analysis of genetic heterogeneity in untreated cancers.未治疗癌症中的遗传异质性分析。
Nat Rev Cancer. 2019 Nov;19(11):639-650. doi: 10.1038/s41568-019-0185-x. Epub 2019 Aug 27.
8
Instantaneous mutation rate in cancer initiation and progression.癌症起始和进展过程中的瞬时突变率。
BMC Syst Biol. 2018 Nov 22;12(Suppl 6):110. doi: 10.1186/s12918-018-0629-z.
9
Precancerous neoplastic cells can move through the pancreatic ductal system.癌前肿瘤细胞可以通过胰腺导管系统移动。
Nature. 2018 Sep;561(7722):201-205. doi: 10.1038/s41586-018-0481-8. Epub 2018 Sep 3.
10
Management of Malignant Biliary Obstruction.恶性胆管梗阻的管理
Semin Intervent Radiol. 2016 Dec;33(4):259-267. doi: 10.1055/s-0036-1592330.
Hepatogastroenterology. 1993 Aug;40(4):384-7.
4
Carcinoma of the ampulla of Vater.壶腹癌
Surg Gynecol Obstet. 1993 Oct;177(4):366-70.
5
The importance of tumour volume in the prognosis of radically treated periampullary carcinomas.肿瘤体积在壶腹周围癌根治性治疗预后中的重要性。
Eur J Surg. 1993 Feb;159(2):95-100.
6
Long-term survival following radical and palliative treatment of patients with carcinoma of the pancreas and papilla of Vater--the prognostic factors influencing the long-term results. A prospective multicentre study.胰腺癌和 Vater 壶腹癌患者根治性和姑息性治疗后的长期生存——影响长期结果的预后因素。一项前瞻性多中心研究。
Eur J Surg Oncol. 1993 Apr;19(2):147-61.
7
The cross rates of growth of human mammary carcinoma.人类乳腺癌的交叉生长率。
Cancer. 1972 Aug;30(2):594-9. doi: 10.1002/1097-0142(197208)30:2<594::aid-cncr2820300241>3.0.co;2-2.
8
Size of the tumor and other factors influencing prognosis of carcinoma of the head of the pancreas.肿瘤大小及其他影响胰头癌预后的因素。
Am J Gastroenterol. 1985 Jun;80(6):459-62.
9
Clinicopathological study on hematogenous metastasis of pancreatic cancer.胰腺癌血行转移的临床病理研究
Jpn J Surg. 1986 Nov;16(6):406-11. doi: 10.1007/BF02470607.
10
Establishment of six human pancreatic cancer cell lines and their sensitivities to anti-tumor drugs.六种人胰腺癌细胞系的建立及其对抗肿瘤药物的敏感性
Tohoku J Exp Med. 1986 Nov;150(3):231-48. doi: 10.1620/tjem.150.231.